Adicet Bio, Inc.
ACET
$9.54
-$0.20-2.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -98.97M | -108.83M | -116.80M | -115.01M | -118.64M |
| Total Depreciation and Amortization | 5.59M | 6.04M | 6.38M | 6.53M | 6.55M |
| Total Amortization of Deferred Charges | 28.00K | 28.00K | 43.00K | 15.00K | 15.00K |
| Total Other Non-Cash Items | 10.79M | 12.10M | 13.66M | 11.40M | 16.20M |
| Change in Net Operating Assets | -1.96M | -676.00K | 1.47M | -1.37M | -2.26M |
| Cash from Operations | -84.53M | -91.34M | -95.25M | -98.44M | -98.14M |
| Capital Expenditure | -438.00K | -283.00K | -1.74M | -1.92M | -2.12M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.27M | 24.42M | 4.13M | 26.73M | -86.49M |
| Cash from Investing | 7.83M | 24.13M | 2.39M | 24.81M | -88.61M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -150.00K | -150.00K | -150.00K | -150.00K | -- |
| Issuance of Common Stock | 75.32M | 75.50M | 75.50M | 404.00K | 404.00K |
| Repurchase of Common Stock | -68.00K | -65.00K | -104.00K | -104.00K | -104.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -22.00K | -- | -- | -- | -- |
| Cash from Financing | 75.08M | 75.28M | 75.25M | 150.00K | 300.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.62M | 8.08M | -17.61M | -73.48M | -186.45M |